A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...

Creative Biogene is proud to announce the launch of its innovative iPSC RNA reprogramming products, specifically designed to enhance the efficiency and safety of iPSC generation.

Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time ...

Cancer cells rapidly adapt to treatments, developing resistance that makes chemotherapy less effective. Researchers used an existing anti-inflammatory drug to disrupt cancer cells’ ability to adapt by ...

Endogenous Retroviruses (ERVs), relics from ancient viral infections, form a significant part of vertebrate genomes, including humans, where they constitute ...

For the roughly 80 million people worldwide living with glaucoma, daily life often means watching the world slowly close in.

Prostate cancer is one of the most common cancers and the second leading cause of cancer-related death in men worldwide. However, the mechanisms controlling the early stages of prostate cancer ...

Add Yahoo as a preferred source to see more of our stories on Google. Unlike typical glaucoma treatments that slow progression, this approach aims to rejuvenate the retinal ganglion cells that die ...

India, April 13 -- Life Biosciences, a clinical-stage biotechnology company focused on reversing diseases of aging, has ...